The First Steps Toward Unity-- My Harvard Days

[Ed. note: In 1979, Sheldon Glashow received the Nobel Prize for physics. But in 1954, he was still a brash and irreverant new graduate student at Harvard. Here, he remembers those heady early days.] To be perfectly honest, I went to Harvard for graduate school largely because Harvard had admitted me—Princeton University had been more choosy. (Since then, I have rarely had occasion to visit Princeton.) What I knew of the place was simply this: 1) It had a snotty reputation. 2) The under

Written bySheldon Glashow
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

[Ed. note: In 1979, Sheldon Glashow received the Nobel Prize for physics. But in 1954, he was still a brash and irreverant new graduate student at Harvard. Here, he remembers those heady early days.]

To be perfectly honest, I went to Harvard for graduate school largely because Harvard had admitted me—Princeton University had been more choosy. (Since then, I have rarely had occasion to visit Princeton.) What I knew of the place was simply this: 1) It had a snotty reputation. 2) The undergraduates threw great parties. 3) Harvard was near Boston, not quite New York but a lot more of a city than Ithaca, where I had been an undergraduate at Cornell. Harvard was Julian Schwinger’s stomping grounds, and Schwinger was as godlike to me as Michael Jackson is to my children.

Precocious, brilliant, and chain-smoking, Schwinger was one of the greatest theoretical physicists, a founder of modern quantum ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies